Health Care/Hospital

Dymicron™ appoints Armen Khachatryan, M.D. to Board of Directors

OREM, Utah, Nov. 10, 2020 /PRNewswire/ -- Dymicron, a privately held, innovative medical device company developing a next generation cervical artificial disc, Triadyme-C™, with a proprietary polycrystalline diamond material and novel, Tri-Lobe articulating design, today announced thatArmen Khach...

2020-11-10 21:15 1180

Volition Veterinary Presents Expert Report Ahead of First Product Launch

* A Look to the Future of Cancer Diagnostics compiles insight from four veterinary cancer experts * Report provides insight into the clinical impact of early cancer detection, and recent advances * Experts also reviewed data on the Nu.Q™ Vet Cancer Screening Test, providing opinion and guid...

2020-11-10 21:00 6117

German MECOTEC Group launches one-stop-solution for deep-freeze, transport, storage and distribution for COVID-19-Vaccines with its first Mobile Hybrid Container

BITTERFELD-WOLFEN, Germany, Nov. 10, 2020 /PRNewswire/ -- Vaccine manufacturers, transport and storage providers are facing major challenges in the fight against the coronavirus. MECOTEC Group has announced a complete-one-stop-solution consisting of: 1. Deep-freeze cooling + 2. Transport + 3. St...

2020-11-10 19:52 1456

mdgroup Joins The Beryl Institute Community

LONDON, Nov. 10, 2020 /PRNewswire/ -- mdgroup, a global digital and patient services company, recently joined The Beryl Institute community as an organisational member. Organisational members create market distinction by supporting a culture where staff at all levels have access to patient exper...

2020-11-10 16:00 1025

Zymo Research Obtains CE IVD Mark for its Quick SARS-CoV-2 Multiplex Kit

Low cost, high-sensitivity diagnostic test for COVID-19 detection IRVINE, Calif., Nov. 10, 2020 /PRNewswire/ -- Zymo Research announced today that it obtained a CE IVD mark for theQuick SARS-CoV-2 Multiplex Kit in compliance with the Directive 98/79/EC of the European Parliament and of the Counc...

2020-11-10 16:00 2094

Inspiration Capital Partners becomes a strategic investor of New Frontier Vitality

HONG KONG, Nov. 10, 2020 /PRNewswire/ -- Inspiration Capital Partners ("ICP") today announced that private equity funds advised by ICP have become strategic capital partners and investors of New Frontier Vitality ("NFV"), the leading integrated post-acute and geriatric healthcare platform inChina...

2020-11-10 15:24 3650

Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine

BASEL, Switzerland, Nov. 10, 2020 /PRNewswire/ -- The rapid development of an effective and safe vaccine against SARS-CoV-2 is a top priority for Swiss Rockets AG. ABasel-based subsidiary, RocketVax AG, was founded to utilize innovative Swiss technologies and expertise to achieve this goal. "The...

2020-11-10 09:00 1734

Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen

BEIJING, Nov. 10, 2020 /PRNewswire/ -- Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharma...

2020-11-10 09:00 2068

Farrer Park Hospital Steps Up Prostate Cancer Treatment with Lutetium-177 PSMA Therapy

SINGAPORE, Nov. 10, 2020 /PRNewswire/ -- Farrer Park Hospital announced today the availability of Lutetium-177 Prostate Specific Membrane Antigen Therapy ("Lu177 PSMA Therapy"), a treatment for advanced prostate cancer.

2020-11-10 08:15 2379

I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody Lemzoparlimab at the 2020 SITC Annual Meeting

SHANGHAI and GAITHERSBURG, Md., Nov. 9, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced initial results from its U.S. phase 1 clinical trial (NCT...

2020-11-09 21:12 3654

Connect Biopharma to Present at the Jefferies Virtual London Healthcare Conference on November 17, 2020

SAN DIEGO and TAICANG, SUZHOU, China, Nov. 9, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune and inflammatory diseases, today announced thatZhe...

2020-11-09 21:00 1003

Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics

Not intended for UK and US based media - Merck out-licenses Phase IIb-ready atacicept to Vera Therapeutics - Phase IIa trial conducted by Merck shows promising results in IgA nephropathy (IgAN), also known as "Berger's disease" - Out-licencing deal includes 10% equity in Vera Therapeutics and up...

2020-11-09 21:00 1483

VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update

AUSTIN, Texas, Nov. 9, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call onFriday, November 13, at 8:30 a.m. Eastern time to discuss its financial and operating results for the third quarter 2020, in addition to providing a b...

2020-11-09 21:00 5243

Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody (W0180) targeting the VISTA checkpoint in patients with solid tumors

TOULOUSE, France, Nov. 9, 2020 /PRNewswire/ -- Pierre Fabre announced today the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its investigational product W0180, an innovative monoclonal antibody targeting VISTA, developed by Pierre ...

2020-11-09 20:57 1853

GenScript Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutralizing Antibody Detection Kit

PISCATAWAY, N.J., Nov. 9, 2020 /PRNewswire/ -- GenScript USA Inc., the world's leading research reagent provider, announced today that the U.S. Food and Drug Administration (FDA) has grantedEmergency Use Authorization (EUA)

2020-11-09 20:30 3532

FTLife Launches "HealthCare 168 Plus" Critical Illness Protector

HONG KONG, Nov. 9, 2020 /PRNewswire/ -- FTLife Insurance Company Limited ("FTLife") today announced the launch of "HealthCare 168 Plus" Critical Illness Protector ("HealthCare 168 Plus" or "the Plan"), aggregated with two first-in-market[1] features including additional monthly financial support ...

2020-11-09 20:08 2519

OrbusNeich® Medical and P+F Products & Features® announce new partnership

Introducing a new portfolio of heart valve products aiming to restore health and extend life HONG KONG, Nov. 9, 2020 /PRNewswire/ -- OrbusNeich and P+F today announced they have entered into an agreement for the exclusive distribution and manufacturing of a range of innovative minimally invasive...

2020-11-09 19:00 2506

The world's largest RCT investigating use of MagicTouch PTA Sirolimus Coated balloon for peripheral artery disease kicks off to a flying start

ZÜRICH, Nov. 9, 2020 /PRNewswire/ -- Concept Medical Inc.,  focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in the SirPAD (Sirolimus in Peripheral Artery Disease) trial.

2020-11-09 18:55 2019

TaiGen Partners with GPCR to develop Burixafor & Taigexyn(R)

TAIPEI, Nov. 9, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") announced today that they have signed an exclusive agreement with GPCR Therapeutics, Inc. ("GPCR"), a leading Korean biotechnology company, for the continued development of Burixafor worldwide and the commercial...

2020-11-09 18:22 1575

Termination of Bridge Biotherapeutics's Collaboration and License Agreement with Boehringer Ingelheim

SEONGNAM, South Korea, Nov. 9, 2020 /PRNewswire/ -- On November 9, 2020, Bridge Biotherapeutics (288330 KQ) reported to the Korea Stock Exchange that the Company and Boehringer Ingelheim have mutually agreed on the termination of the Collaboration and License Agreement entered into inJuly 2019 to...

2020-11-09 18:07 1365
1 ... 600601602603604605606 ... 807